Bluejay Diagnostics (BJDX) PT Lowered to $8 at Dawson James on Dilution, Reiterates "Buy" Rating, Sees 30% Chance of Success of Symphony
Tweet Send to a Friend
Dawson James analyst Jason Kolbert lowered the price target on Bluejay Diagnostics (NASDAQ: BJDX) to $8.00 (from $10.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
